Migraine
6 competing products in clinical development for Migraine.
Pipeline by Phase
Phase 11
Phase 23
Phase 31
Approved1
All Products (6)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Galcanezumab + Erenumab | Eli Lilly | Approved | Completed | 85 |
| Lasmiditan + Placebo | Eli Lilly | Phase 3 | Completed | 77 |
| Lasmiditan + Placebo | Eli Lilly | Phase 2 | Completed | 52 |
| ABP-450 | AEON Biopharma | Phase 2 | Terminated | 44 |
| ABP-450 + Placebo | AEON Biopharma | Phase 2 | Completed | 44 |
| lasmiditan 200 mg + Sumatriptan + matching placebo | Eli Lilly | Phase 1 | Completed | 33 |